Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.

Transbilix: Full Drug Profile

Medically reviewed by Min Clinic Staff | Updated: January 2026

Transbilix - General Information

A water-soluble radiographic contrast media for cholecystography and intravenous cholangiography. [PubChem]

 

Pharmacology of Transbilix

Not Available

 

Additional information about Transbilix

Transbilix Indication

Used as a contrast agent for cholecystography and intravenous cholangiography.

Mechanism Of Action
Organic iodine compounds block x-rays as they pass through the body, thereby allowing body structures containing iodine to be delineated in contrast to those structures that do not contain iodine. The degree of opacity produced by these iodinated organic compounds is directly proportional to the total amount (concentration and volume) of the iodinated contrast agent in the path of the x-rays. Transbilix's primary excretion through the hepato-biliary system and concentration in bile allows visualization of the gallbladder and biliary ducts.
Generic Name
Iodipamide
Synonyms
3,3'-[(1,6-dioxohexane-1,6-diyl)diimino]bis(2,4,6-triiodobenzoic acid); Iodipamic acid; Adipiodone; Adipiodonum [INN-Latin]; Adipiodona [INN-Spanish]; IDB
Drug Category
Contrast Media
Drug Type
Small Molecule; Approved
Other Brand Names containing Iodipamide
Transbilix; Cholospect; Cholografin; Biligrafin; Bilignostum; Bilignost;
Toxicity (Overdose)
Acute IV LD50 is 5000 mg/kg in rat, 3195 mg/kg in mouse, and 1200 mg/kg in dog.
Biotransformation
Hepatic.
Dosage Forms of Transbilix
Injection, solution Intravenous drip
Chemical IUPAC Name
3-[[6-[(3-carboxy-2,4,6-triiodophenyl)amino]-6-oxohexanoyl]amino]-2,4,6-triiodobenzoic acid
Chemical Formula
C20H14I6N2O6
Organisms Affected
Humans and other mammals